바이오테크 보도자료
-
- Takeda Announces Publication of Data from SOLSTICE, a Pivotal Phase 3 Trial for LIVTENCITY™ (Maribavir) in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the data from the pivotal Phase 3 SOLSTICE clinical trial of LIVTENCITY™ (maribavir, TAK-620) in post-transplant refractory[†] CMV infections with or without...
- 2021년 12월 09일
-
- Aleph Farms and WACKER Develop Open Supply Chain Solution for Proteins Used in Large-Scale Production of Cultivated Meat
- Aleph Farms, the first cultivated meat company to grow steaks directly from non-genetically engineered animal cells and WACKER, a supplier of leading protein production technologies, today announced the development of streamlined production proces...
- 2021년 12월 08일
-
- Takeda Unveils New Research to Advance Patient Care in Hematology and Oncology at 63rd American Society of Hematology (ASH) Annual Meeting
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it will present a total of 23 company-sponsored abstracts at the 63rd American Society of Hematology (ASH) Annual Meeting being held December 11-14, 2021 in ...
- 2021년 12월 08일
-
- Andersen Global Strengthens European Platform with Addition of Collaborating Firm in Czech Republic
- Andersen Global enters into a Collaboration Agreement with Prague-based law firm rutland & partners, adding breadth to its platform in Europe. Rutland & partners, established in 2010 by Founding Partner Monika Rutland, focuses on corporate, real e...
- 2021년 12월 08일
-
- Maria Teresa Hilado to Join Galderma’s Advisory Committee
- Galderma, the world’s largest independent dermatology company, announced today that Maria Teresa “Tessa” Hilado will join its Advisory Committee, effective January 1, 2022. Ms. Hilado currently serves on the board of directors at Campbell Soup Com...
- 2021년 12월 08일
-
- Olympus Sets Sights on Growth in Its Refocused Medical Business
- Olympus Corporation (“Olympus” - Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi), has clarified the direction of its medical business with the aim of achieving further growth and profitability by elevating the standa...
- 2021년 12월 07일
-
- Yokogawa Develops Single Cellome System SS2000 for Subcellular Sampling
- Yokogawa Electric Corporation (TOKYO:6841) announces that it has developed the Single Cellome™ System SS2000, a single-cell analysis solution that utilizes high-resolution images captured with a confocal microscope to automatically and accurately ...
- 2021년 12월 07일
-
- Galderma Announces New Data Demonstrating the Positive Anti-inflammatory Effect and Mode of Action of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis
- Galderma today announced that the Journal of Allergy and Clinical Immunology has published gene expression data that demonstrate the positive anti-inflammatory effect and mode of action of nemolizumab in patients with moderate to severe Prurigo No...
- 2021년 12월 07일
-
- Yokogawa Acquires PXiSE, a Developer of High-speed Control Software for Grids and Renewable Energy Assets
- Yokogawa Electric Corporation (TOKYO:6841) announces it has acquired all of the outstanding shares of PXiSE Energy Solutions LLC., a San Diego-based developer of software that enables utilities and other grid operators to deliver reliable and stab...
- 2021년 12월 07일
-
- PDC*line Pharma Raises €17.5 Million in Series B2 Financing Round
- PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active off-the-shelf cancer vaccine, announces today the completion of its Series B2 round of financing. The company has raised a total of €17.5 millio...
- 2021년 12월 06일
-
- Vifor Pharma comments on market speculations
- Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Due to current market speculations, Vifor Pharma Group states the following: Vifor Pharma Group systematically reviews options that can strengthen its market position and/or accelerate th...
- 2021년 12월 03일
-
- New Report From Arthur D. Little Highlights Full Potential of Artificial Intelligence for Business
- Arthur D. Little (ADL) has launched a new report which examines how artificial intelligence (AI) can be used to its full potential in the context of business decision making. The report - ‘From Insight to Impact’ looks at how companies can use AI ...
- 2021년 12월 03일
전시회
